AntioxidantFoods.com
PH: 800-897-0321
Close this pop-up window

A Silicate Mineral Supplement, Microhydrin, Traps Reduced
Hydrogen Providing In Vitro Biological Antioxidant Properties

Page: 1| 2 | 3 | 4 | 5 | 6 | 7

Super Oxide Scavenging Assays With Microhydrin

The superoxide mediated reduction of cytochrome c showed that the reduced silicate mineral inhibited the superoxide-mediated reduction of cytochrome c, indicating that the reduced silicate is reducing, or scavenging, the superoxide radical also:

Mic (H:-) + O.2- + H+ ½ Mic + H2O2

In this assay Microhydrin was found to inhibit and prevent the reduction of cytochrome c by superoxide:

O.2- + Cyt c(Fe+3) ½ O2 + Cyt c(Fe+2)

An alternative assay to further elucidate the activity of the reduced silicate mineral, observed the oxidation of epinephrine to adrenochrome by superoxide (unpublished data).

Microhydrin
O.2- + epinephrine ½ H2O2 + adrenochrome

Superoxide
free radical
Hydrogen peroxide

Data is shown in Table 1 for superoxide dismutase-like (SOD) activity based on the oxidation of epinephrine by superoxide.

In this assay the reduced hydrogen mineral silicate (Microhydrin) scavenged the superoxide ion again. Quantitatively, half-maximal inhibition was achieved at a Microhydrin concentration of 90 µg/ml (Table 1). When concentrations of Microhydrin were at 60 µg/ml or When concentrations of Microhydrin were at 60 µg/ml or greater, epinephrine oxidation was inhibited showing that the silicate mineral reduced the superoxide free radical. The assay conditions utilized superoxide dismutase at a concentration of 50µg/ml with a conversion rate of 0.15 µg/ml (unpublished data) (Table 1, Figure 2).

NAD Reduction With Microhydrin

The ability of Microhydrin to reduce NAD+ to NADH was also examined. The redox potential for this reaction is –0.32 V (– 320 mV), requiring a fairly strong reducing agent. Microhydrin reduced NAD+ to NADH. The reduction of NAD+ was verified by scanning the absorption spectrum from 200 nm to 500 nm. In all subsequent studies NAD+ reduction was monitored as the difference between two wavelengths (340 nm to 500 nm).

The 500 nm wavelength served as a reference (independent of NAD+ reduction, but controlling for turbidity changes due to the light scattering effect of the silicate) (Figure 3). NAD+ could be titrated by sequential addition of aliquots of Microhydrin in a linear fashion.

Microhydrin was suspended for 30 min. at 10mg/ml. Microhydrin was added incrementally to 60µM NAD+(Figure 3).

COPYRIGHT NOTICE. Copyright © 2002 Royal BodyCare, Inc,
and/or its suppliers, 2301 Crown Court, Irving, TX 75038. U.S.A. All rights reserved.

The information and articles on this website are for educational purposes only.
They should not be regarded or relied on as medical advice. 
This information has not been evaluated by the FDA.
RBC products are not intended to diagnose, treat, cure or prevent any disease.
Results may vary from person to person. Please consult your health
practitioner if you have health problems.